CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Biostage, Inc.  (BSTG)
Other Ticker:  
 
 

BSTG's Operating Income Growth by Quarter and Year

Biostage,'s Operating Income results by quarter and year




BSTG Operating Income (in millions $) FY 2018 FY 2017 FY 2016 FY 2015
IV Quarter December -2.10 -1.44 -3.58 0.00
III Quarter September -2.23 -3.25 -3.15 0.00
II Quarter June -2.03 -3.73 -2.92 0.00
I Quarter March -1.48 -3.05 -2.47 0.00
FY   -7.84 -11.47 -12.12 -



BSTG Operating Income forth quarter 2018 Y/Y Growth Comment
Biostage, Inc. in the forth quarter recorded Operating Loss of $ -2.10 millions.

According to the results reported in the forth quarter, Biostage, Inc. achieved the best Operating Income growth in Medical Equipment & Supplies industry. While Biostage, Inc.' s Operating Income no change of % ranks overall at the positon no. in the forth quarter.

Explain Operating Income growth


BSTG Operating Income ( Y/Y Growth %) 2018
2017 2016 2015
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Biostage,'s forth quarter 2018 Operating Income $ -2.10 millions BSTG's Income Statement
Biostage,'s forth quarter 2017 Operating Income $ -1.44 millions Quarterly BSTG's Income Statement
New: More BSTG's historic Operating Income Growth >>


BSTG Operating Income (Quarter on Quarter Growth %)

2018
2017 2016 2015
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Operating Income forth quarter 2018 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Operating Income forth quarter 2018 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Operating Income by Quarter for the Fiscal Years 2015, 2016, 2017, 2018

Biostage,'s Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


BSTG's IV. Quarter Q/Q Operating Income Comment
Even if Biostage, Inc. in the IV. Quarter 2018 revealed Operating Loss of $ -2.10 millions, management said, that current results point to slight up side relative to the -2.23 millions in the third quarter.

Within Medical Equipment & Supplies industry Biostage, Inc. achieved highest sequential Operating Income growth. While Biostage,'s Operating Income growth quarter on quarter, overall rank is .


Operating Income Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


BSTG's IV. Quarter Q/Q Operating Income Comment
Although Biostage, Inc. in the IV. Quarter 2018 showed Operating Loss of $ -2.10 millions, it should be point out, that current results are recovery compare to the -2.23 millions in the third quarter.

Within Medical Equipment & Supplies industry Biostage, Inc. achieved highest sequential Operating Income growth. While Biostage,'s Operating Income growth quarter on quarter, overall rank is .


Biostage,'s 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(Dec 31 2018)
12 Months Ending
(Sep 30 2018)
12 Months Ending
(Jun 30 2018)
12 Months Ending
(Mar 31 2018)
12 Months Ending
(Dec 31 2017)
Cumulative Operating Income 12 Months Ending $ -7.84 $ -7.18 $ -8.21 $ -9.90 $ -11.47
Y / Y Operating Income Growth (TTM) - - - - -
Year on Year Operating Income Growth Overall Ranking # # # # #
Seqeuential Operating Income Change (TTM) - - - - -
Seq. Operating Income Growth (TTM) Overall Ranking # # # # #




Cumulative Operating Income growth Comment


Biostage, Inc. achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Operating Income growth Comment


Biostage, Inc. achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Operating Income Growth
Medical Equipment & Supplies Industry Operating Income Growth Trends and Statistics
Healthcare Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
BSTG's Operating Income Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for BSTG's Competitors
Operating Income Growth for Biostage,'s Suppliers
Operating Income Growth for BSTG's Customers

You may also want to know
BSTG's Annual Growth Rates BSTG's Profitability Ratios BSTG's Asset Turnover Ratio BSTG's Dividend Growth
BSTG's Roe BSTG's Valuation Ratios BSTG's Financial Strength Ratios BSTG's Dividend Payout Ratio
BSTG's Roa BSTG's Inventory Turnover Ratio BSTG's Growth Rates BSTG's Dividend Comparisons



Companies with similar Operating Income no change for the quarter ending Dec 31 2018 within Healthcare SectorY/Y Change %Operating Income for the quarter ending Dec 31 2018
Iradimed Corp  79.33 %$ 79.328 millions
Qiagen Nv  73.76 %$ 73.760 millions
Penumbra Inc  72.95 %$ 72.951 millions
Abbott Laboratories  68.60 %$ 68.596 millions
Intricon Corp  65.59 %$ 65.586 millions
Civitas Solutions, Inc.  62.68 %$ 62.681 millions
Dariohealth Corp.  60.75 %$ 60.750 millions
China Yct International Group, Inc.  56.77 %$ 56.774 millions
Ani Pharmaceuticals Inc  55.10 %$ 55.102 millions
Johnson & Johnson  51.61 %$ 51.606 millions
Eagle Pharmaceuticals, Inc.  50.60 %$ 50.603 millions
Celgene Corp  50.21 %$ 50.208 millions
Merck & Co., Inc.  45.84 %$ 45.836 millions
Regeneron Pharmaceuticals Inc  44.82 %$ 44.823 millions
Baxter International Inc  40.64 %$ 40.636 millions
Abiomed Inc  39.29 %$ 39.291 millions
Bio-techne Corp  39.15 %$ 39.154 millions
Myriad Genetics Inc  38.64 %$ 38.636 millions
Lilly Eli & Co  37.77 %$ 37.773 millions
Hill-rom Holdings, Inc.  35.89 %$ 35.893 millions
Fresenius Medical Care Ag & Co. Kgaa  32.35 %$ 32.352 millions
Ensign Group, Inc  31.76 %$ 31.764 millions
Teleflex Incorporated  31.20 %$ 31.200 millions
Jazz Pharmaceuticals Plc  31.05 %$ 31.054 millions
Meridian Bioscience Inc  30.89 %$ 30.889 millions
Orasure Technologies Inc  23.14 %$ 23.137 millions


             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

UMHL's Profile

Stock Price

UMHL's Financials

Business Description

Fundamentals

Charts & Quotes

UMHL's News

Suppliers

UMHL's Competitors

Customers & Markets

Economic Indicators

UMHL's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071